Department of Periodontology and Oral Diseases, Medical University of Lodz, 90-419 Lodz, Poland.
Department of Neurology, Medical University of Lodz, 90-419 Lodz, Poland.
Nutrients. 2020 Aug 27;12(9):2614. doi: 10.3390/nu12092614.
Periodontitis is a chronic multifactorial inflammatory disease that leads to the loss of supportive tissues around the teeth with gradual deterioration of masticatory function and esthetics, resulting eventually in the decrease of the life quality. Host immune response triggered by bacterial biofilm is responsible for the chronic periodontal inflammation and ongoing tissue loss. Omega-3 polyunsaturated fatty acids (PUFA) such as eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA) have anti-inflammatory properties, thus may be used for the treatment of chronic inflammatory diseases. In this study, we aimed to evaluate the effect of dietary supplementation with omega-3 PUFA in the patients with stage III and IV periodontitis. Thirty otherwise healthy patients were treated with scaling and root planning (SRP). In the test group ( = 16), patients were additionally supplemented with 2.6 g of EPA and 1.8 g of DHA. In the control group ( = 14), patients received only SRP. Periodontal examination was performed at baseline and three months following initial therapy. Salivary samples were taken twice at baseline and at the end of the experiment. We found that there was a statistically significant reduction in the bleeding on probing (BOP) and improvement of clinical attachment loss (CAL) at three months in the test group compared to the control group. Moreover, a statistically significant higher percentage of closed pockets (probing depth ≤ 4 mm without BOP) was achieved in the test group vs. control group after three months of treatment. Accordingly, the levels of pro-inflammatory cytokines/chemokines interleukin (IL)-8 and IL-17 were markedly lower, while the level of anti-inflammatory IL-10 was significantly higher in the salivary samples of the patients supplemented with omega-3 PUFA at three months in comparison to the patients treated with SRP alone. Our findings demonstrate that dietary intervention with high-dose of omega-3 PUFA during non-surgical therapy may have potential benefits in the management of periodontitis.
牙周炎是一种慢性多因素炎症性疾病,会导致牙齿周围的支持组织逐渐丧失,咀嚼功能和美观度逐渐恶化,最终导致生活质量下降。细菌生物膜引发的宿主免疫反应是导致慢性牙周炎和持续组织丧失的原因。ω-3 多不饱和脂肪酸(PUFA),如二十碳五烯酸(EPA)和二十二碳六烯酸(DHA)具有抗炎作用,因此可用于治疗慢性炎症性疾病。在本研究中,我们旨在评估ω-3 PUFA 饮食补充对 III 期和 IV 期牙周炎患者的疗效。30 名其他健康的患者接受了牙周洁治和根面平整术(SRP)治疗。在试验组(n = 16)中,患者还额外补充了 2.6 克 EPA 和 1.8 克 DHA。在对照组(n = 14)中,患者仅接受了 SRP 治疗。在初始治疗后三个月进行牙周检查。在基线和实验结束时采集了两次唾液样本。我们发现,与对照组相比,试验组在三个月时的探诊出血(BOP)显著减少,临床附着丧失(CAL)得到改善。此外,在三个月的治疗后,试验组的探诊深度≤4mm 且无 BOP 的封闭袋(口袋)比例显著高于对照组。相应地,与单独接受 SRP 治疗的患者相比,补充 ω-3 PUFA 的患者在三个月时的唾液样本中促炎细胞因子/趋化因子白细胞介素(IL)-8 和 IL-17 的水平显著降低,抗炎性 IL-10 的水平显著升高。我们的研究结果表明,在非手术治疗期间,高剂量 ω-3 PUFA 的饮食干预可能对牙周炎的管理具有潜在益处。